8.32
Kala Bio Inc Borsa (KALA) Ultime notizie
Technical analysis overview for KALA BIO Inc. stock2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - Newser
What’s next for KALA BIO Inc. stock priceGap Down & Long-Term Safe Investment Plans - Newser
Using Python tools to backtest KALA BIO Inc. strategiesGold Moves & AI Forecast for Swing Trade Picks - Newser
Can KALA BIO Inc. recover in the next quarterJuly 2025 Decliners & Consistent Growth Equity Picks - Newser
How KALA BIO Inc. stock performs during market volatility2025 Trading Volume Trends & Daily Growth Stock Investment Tips - Newser
Is KALA BIO Inc. a Top Dividend Stock to Watch in 2025Earnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Price momentum metrics for KALA BIO Inc. explainedQuarterly Profit Review & Weekly Breakout Stock Alerts - Newser
KALA BIO Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Movers & AI Optimized Trading Strategy Guides - Newser
KALA BIO Inc. stock trend forecastCEO Change & Smart Money Movement Alerts - Newser
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade - MSN
Institutional Tools Highlight Unusual Flow in KALA BIO Inc.Bear Alert & Low Risk Growth Stock Ideas - newsyoung.net
KALA BIO Inc. Building a Base Near Support2025 Retail Activity & Proven Capital Preservation Tips - sundaytimes.kr
Comparing KALA BIO Inc. in custom built stock radars2025 Risk Factors & Intraday High Probability Alerts - Newser
Statistical indicators supporting KALA BIO Inc.’s strengthNew Guidance & Safe Entry Point Alerts - Newser
Is KALA BIO Inc. showing insider buyingROIC-Focused Investment List - thegnnews.com
Why KALA BIO Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser
Using portfolio simulators with KALA BIO Inc. includedFree Swing Setup With Technical Confirmation - Newser
What makes KALA BIO Inc. stock price move sharplyFree Risk Managed Intraday Trade Alerts - Newser
Can volume confirm reversal in KALA BIO Inc.Free AI Screening for Swing Trade Picks - Newser
Kala Bio Reports Q2 2025 Earnings: EPS -$1.82, Revenue Unavailable; Focus on Advancing KPI-012 for Rare Eye Diseases. - AInvest
Trend analysis for KALA BIO Inc. this weekWeekly Trend Watch with Market Signals - Newser
What drives KALA BIO Inc.’s stock priceStocks with 300% Upside - sisaissue.com
KALA BIO: Q2 Earnings Snapshot - Greenwich Time
KALA BIO (NASDAQ:KALA) Stock Rating Lowered by Wall Street Zen - Defense World
Momentum divergence signals in KALA BIO Inc. chartShort-Term Profit Alert With Entry Forecast - Newser
Kala Bio (KALA) Q2 Loss Widens 15% - AOL.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Kala Bio Q2 Loss Widens 15%, KPI-012 Enrollment Completed - AInvest
Biotech's Long Game: Assessing KALA BIO's Q2 Loss in the Context of Strategic Innovation - AInvest
Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool
KALA BIO, Inc. Completes Patient Enrollment in Phase 2b CHASE Trial for KPI-012 in Persistent Corneal Epithelial Defect, Reports Financial Results and Upcoming Milestones - Quiver Quantitative
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
KALA Bio Completes Phase 2b Trial Enrollment for Novel PCED Eye Treatment | KALA Stock News - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):